99 related articles for article (PubMed ID: 2895712)
61. Interactions between thyreostimulin and PAF-acether on thyroid cell metabolism.
Haye B; Aublin JL; Champion S; Lambert B; Jacquemin C
Eur J Pharmacol; 1984 Sep; 104(1-2):125-31. PubMed ID: 6094205
[TBL] [Abstract][Full Text] [Related]
62. Vascular actions of synthetic PAF-acether (a synthetic platelet-activating factor) in the rat: evidence for a platelet independent mechanism.
Sánchez-Crespo M; Alonso F; Iñarrea P; Alvarez V; Egido J
Immunopharmacology; 1982 Apr; 4(2):173-85. PubMed ID: 7085259
[TBL] [Abstract][Full Text] [Related]
63. CD26 surface antigen expression on peripheral blood T lymphocytes from children with Down's syndrome (trisomy 21).
Bertotto A; Gerli R; Spinozzi F; Muscat C; Fabietti GM; Crupi S; Castellucci G; De Benedictis FM; De Giorgi G; Britta R
Scand J Immunol; 1994 Jun; 39(6):633-6. PubMed ID: 7912005
[TBL] [Abstract][Full Text] [Related]
64. Effect of methylxanthine derivatives on T cell activation.
Singer JW; Bianco JA; Takahashi G; Simrell C; Petersen J; Andrews DF
Bone Marrow Transplant; 1992 Jul; 10(1):19-25. PubMed ID: 1355384
[TBL] [Abstract][Full Text] [Related]
65. Inflammatory characteristics of platelet activating factor (PAF-acether) in human skin.
Archer CB; Page CP; Paul W; Morley J; MacDonald DM
Br J Dermatol; 1984 Jan; 110(1):45-50. PubMed ID: 6581831
[TBL] [Abstract][Full Text] [Related]
66. Presence of paf-acether in human thymus.
Salem P; Denizot Y; Pitton C; Dulioust A; Bossant MJ; Benveniste J; Thomas Y
FEBS Lett; 1989 Oct; 257(1):49-51. PubMed ID: 2806565
[TBL] [Abstract][Full Text] [Related]
67. Effect of synthetic PAF-acether on human neutrophil function.
Czarnetzki BM; Benveniste J
Agents Actions; 1981 Dec; 11(6-7):549-50. PubMed ID: 7041568
[TBL] [Abstract][Full Text] [Related]
68. Synergistic interaction between prostaglandins and PAF-acether in experimental animals and man.
Archer CB; Frohlich W; Page CW; Paul W; Morley J; MacDonald DM
Prostaglandins; 1984 Mar; 27(3):495-501. PubMed ID: 6203139
[TBL] [Abstract][Full Text] [Related]
69. Influence of PAF-acether on lecithin-oriented multibilayers monitored by ESR: interaction of PAF-acether with cholesterol.
Olivier JL; Chachaty C; Wolf C; Bereziat G
Biochimie; 1989 Jan; 71(1):105-9. PubMed ID: 2541796
[TBL] [Abstract][Full Text] [Related]
70. Paf-acether-induced superoxide anion generation in human B cell line.
Leca G; Joly F; Vazquez A; Galanaud P; Ninio E
FEBS Lett; 1990 Aug; 269(1):171-3. PubMed ID: 2167241
[TBL] [Abstract][Full Text] [Related]
71. Use of an antisense RNA expression system to explore functions of PKC isoenzymes in T-cell activation.
Freire-Moar J; Tsutsumi A; Barja P
Ann N Y Acad Sci; 1992 Oct; 660():288-90. PubMed ID: 1364093
[No Abstract] [Full Text] [Related]
72. A CD2+ subset of non-malignant peripheral blood lymphocytes from patients with Sézary syndromes overexpress the low-molecular-weight GTP-binding protein Rab2.
Culine S; Honore N; Closson V; Lang P; Bertoglio J; Laroche L; Bussel A; Racadot E; Hovnanian A; Dubertret L
Leukemia; 1993 Apr; 7(4):601-8. PubMed ID: 8096558
[TBL] [Abstract][Full Text] [Related]
73. Synergism between platelet-activating factor (PAF-acether) and prostaglandin E2 in man.
McGivern DV; Basran GS
Eur J Pharmacol; 1984 Jun; 102(1):183-5. PubMed ID: 6592097
[TBL] [Abstract][Full Text] [Related]
74. Effect of platelet activating factor on the human nasal mucosa.
Pipkorn U; Karlsson G; Bake B
Allergy; 1984 Feb; 39(2):141-5. PubMed ID: 6703263
[TBL] [Abstract][Full Text] [Related]
75. Expression of soluble recombinant glycoproteins with predefined glycosylation: application to the crystallization of the T-cell glycoprotein CD2.
Davis SJ; Puklavec MJ; Ashford DA; Harlos K; Jones EY; Stuart DI; Williams AF
Protein Eng; 1993 Feb; 6(2):229-32. PubMed ID: 8097313
[No Abstract] [Full Text] [Related]
76. Platelet-activating factor (PAF-acether) and macrophages. II. Phagocytosis-associated release of PAF-acether from rat peritoneal macrophages.
Mencia-Huerta JM; Benveniste J
Cell Immunol; 1981 Jan; 57(2):281-92. PubMed ID: 6260384
[No Abstract] [Full Text] [Related]
77. Simultaneous measurement of cell surface and intracellular antigens by multiple flow cytometry.
Sumner H; Abraham D; Bou-Gharios G; Plater-Zyberk C; Olsen I
J Immunol Methods; 1991 Feb; 136(2):259-67. PubMed ID: 1671872
[TBL] [Abstract][Full Text] [Related]
78. The structure of the human CD2 gene and its expression in transgenic mice.
Lang G; Wotton D; Owen MJ; Sewell WA; Brown MH; Mason DY; Crumpton MJ; Kioussis D
EMBO J; 1988 Jun; 7(6):1675-82. PubMed ID: 2901953
[TBL] [Abstract][Full Text] [Related]
79. Binding of organic acids to surface receptors of lymphocytes as an immunosuppressive mechanism in uremia.
Sanaka T; Hayasaka Y; Kawashima Y; Takuma T; Sugino N; Ota K; Gulyassy PF
Adv Exp Med Biol; 1987; 223():165-9. PubMed ID: 3502315
[No Abstract] [Full Text] [Related]
80. Decreased skin response to intradermal platelet-activating factor (PAF-acether) in cancer patients.
Burtin C; Noirot C; Scheinmann P; Paupe J; Benveniste J
J Allergy Clin Immunol; 1990 Sep; 86(3 Pt 1):418-9. PubMed ID: 2212415
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
